A short total synthesis of (±)-paroxetine and a formal asymmetric synthesis of (–)-paroxetine
A short total synthesis of (±)-paroxetine and a formal asymmetric synthesis of (–)-paroxetine
Paroxetine, a selective serotonin reuptake inhibitor, is a potent drug used for the treatment of depression for more than 20 years. Although numerous syntheses have been reported for this molecule, the manufacturing process still uses a resolution step, as it remains the shortest way to access paroxetine on a large scale.
Our synthesis of paroxetine offers an alternative solution, delivering the final compound in only six steps from commercially available material. This has been possible thanks to the use of both organo- and organometallic catalysis to introduce the two chiral centres. Formaldehyde has been used in a direct proline-catalysed aldol reaction, allowing the selective introduction of a hydroxymethyl group with good atom economy. Optimisation of a cobalt-catalysed Kumada-type Csp3-Csp2 cross coupling reaction on a secondary bromide enabled us to introduce the aryl substituent in the 4-position. Furthermore, the generation of a configurationally labile cobalt intermediate in the cross coupling reaction has been successfully exploited to develop a diastereoselective arylation. The use of methanol for the introduction of a hydroxymethyl group via transfer hydrogenative coupling has also been briefly investigated for incorporation in an asymmetric synthesis of abacavir.
Despiau, Carole
63dedec0-1553-4032-806d-f0938804b3c7
9 December 2013
Despiau, Carole
63dedec0-1553-4032-806d-f0938804b3c7
Linclau, Bruno
19b9cacd-b8e8-4c65-af36-6352cade84ba
Despiau, Carole
(2013)
A short total synthesis of (±)-paroxetine and a formal asymmetric synthesis of (–)-paroxetine.
University of Southampton, School of Chemistry, Doctoral Thesis, 232pp.
Record type:
Thesis
(Doctoral)
Abstract
Paroxetine, a selective serotonin reuptake inhibitor, is a potent drug used for the treatment of depression for more than 20 years. Although numerous syntheses have been reported for this molecule, the manufacturing process still uses a resolution step, as it remains the shortest way to access paroxetine on a large scale.
Our synthesis of paroxetine offers an alternative solution, delivering the final compound in only six steps from commercially available material. This has been possible thanks to the use of both organo- and organometallic catalysis to introduce the two chiral centres. Formaldehyde has been used in a direct proline-catalysed aldol reaction, allowing the selective introduction of a hydroxymethyl group with good atom economy. Optimisation of a cobalt-catalysed Kumada-type Csp3-Csp2 cross coupling reaction on a secondary bromide enabled us to introduce the aryl substituent in the 4-position. Furthermore, the generation of a configurationally labile cobalt intermediate in the cross coupling reaction has been successfully exploited to develop a diastereoselective arylation. The use of methanol for the introduction of a hydroxymethyl group via transfer hydrogenative coupling has also been briefly investigated for incorporation in an asymmetric synthesis of abacavir.
Text
__soton.ac.uk_ude_PersonalFiles_Users_lp5_mydocuments_Theses PDF files_Thesis_CDespiau_final.pdf
- Other
More information
Published date: 9 December 2013
Organisations:
University of Southampton, Chemistry
Identifiers
Local EPrints ID: 360900
URI: http://eprints.soton.ac.uk/id/eprint/360900
PURE UUID: d8f83ec7-405b-470d-a854-40ea0ddac18f
Catalogue record
Date deposited: 10 Jan 2014 14:58
Last modified: 15 Mar 2024 03:05
Export record
Contributors
Author:
Carole Despiau
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
